SYMPTOMATIC HYPOMAGNESEMIA INDUCED BY PROTON-PUMP INHIBITORS (PPIs). A KNOWN ADVERSE EVENT THAT IS WORTH RECALLING.
- 1 January 2021
- journal article
- letter
- Published by Sociedad Espanola de Patologia Digestiva (SEPD) in Revista Española de Enfermedades Digestivas
- Vol. 113 (10), 728
- https://doi.org/10.17235/reed.2021.7882/2021
Abstract
Hypomagnesemia is one of the uncommon adverse effects of drugs as widely used as proton pump inhibitors, which we must know in order to include it in our differential diagnoses in normal clinical practice. It has an essential suspicion diagnosis with easy treatment to avoid further complications. We report a case of symptomatic hypomagnesemia diagnosed in our hospital, with delay in diagnosis due to lack of initial suspicion and with immediate improvement after withdrawal of the drug.Keywords
This publication has 3 references indexed in Scilit:
- The Association between the Use of Proton Pump Inhibitors and the Risk of Hypomagnesemia: A Systematic Review and Meta-AnalysisPLOS ONE, 2014
- Recurrent confusional episodes associated with hypomagnesaemia due to esomeprazolBMJ Case Reports, 2013
- Systematic review: hypomagnesaemia induced by proton pump inhibitionAlimentary Pharmacology & Therapeutics, 2012